ストックスクリーナーアプリを入手
21.25
4.21%
0.805
Immunome Inc (IMNM) 最新ニュース
Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms - TechStock²
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Jim Cramer on Immunome: “If You Want to Speculate on It, Fine” - Insider Monkey
Is Immunome Inc. stock supported by strong fundamentalsMarket Rumors and News & Affordable Market Investment - ulpravda.ru
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference - BioSpace
Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update - TechStock²
Immunome’s Stock Under the Microscope: Can IMNM Turn Recent Volatility Into a Breakout? - AD HOC NEWS
Immunome (NASDAQ:IMNM) Shares Down 7%Time to Sell? - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Decliners Report: Can Immunome Inc stock deliver strong Q4 earningsJuly 2025 Outlook & Weekly High Return Opportunities - moha.gov.vn
Immunome’s Phase 1 Cancer Study: A Potential Game-Changer? - MSN
Understanding the Setup: (IMNM) and Scalable Risk - Stock Traders Daily
Top Executive Makes Bold Move With Fresh Immunome Stock Purchase - TipRanks
Insider Buying: Clay Siegall Acquires Additional Shares of Immun - GuruFocus
Immunome (NASDAQ:IMNM) CEO Purchases $100,018.35 in Stock - MarketBeat
Immunome (IMNM) CEO Siegall buys $100k in shares By Investing.com - Investing.com Nigeria
Immunome (IMNM) CEO Siegall buys $100k in shares - Investing.com
Top Biotech Stocks To ConsiderDecember 15th - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM) - The Globe and Mail
Former CEO Of Seagen Buys Shares Of Immunome – Insider Weekends (NASDAQ:IMNM) - Seeking Alpha
Why Immunome stock surged today - MSN
Immunome (IMNM): Assessing Valuation After Strong Phase 3 Varegacestat Data and $400 Million Equity Raise - Sahm
Immunome (IMNM) price target increased by 33.44% to 34.94 - MSN
Immunome, a top 3% stock, just delivered a 'knockout' to Merck KGaA - MSN
Immunome (NASDAQ:IMNM) Director Isaac Barchas Sells 383,200 Shares - MarketBeat
Guggenheim reiterates Buy rating on Immunome stock following $400M financing By Investing.com - Investing.com South Africa
Guggenheim reiterates Buy rating on Immunome stock following $400M financing - Investing.com Nigeria
Hedge Fund and Insider Trading News: Michael Hintze, Xavier Majic, Stanley Druckenmiller, Warren Buffett, Bill Ackman, Bridgewater Associates, Citadel Investment Group, Infini Capital, Immunome Inc (IMNM), White Mountains Insurance Group Ltd (WTM), a - Insider Monkey
Siegall buys Immunome (IMNM) shares worth $149k By Investing.com - Investing.com Nigeria
Immunome (NASDAQ:IMNM) Insider Purchases $204,900.00 in Stock - MarketBeat
Siegall buys Immunome (IMNM) shares worth $149k - Investing.com India
Tsai Philip buys $204,899 in Immunome stock By Investing.com - Investing.com South Africa
Tsai Philip buys $204,899 in Immunome stock - Investing.com
Immunome CTO Philip Tsai Buys 10,000 Shares - TradingView — Track All Markets
Will Immunome Inc. stock see insider buyingMarket Growth Summary & Verified Swing Trading Watchlist - Улправда
Clay Siegall Bought 5.8% More Shares In Immunome - simplywall.st
Immunome Chairman Acquires 5.8% More Stock - Yahoo Finance
Aug Breakouts: Will Immunome Inc. stock see insider buyingWeekly Profit Report & Free AI Powered Buy and Sell Recommendations - Улправда
How institutional buying supports Immunome Inc. stock2025 Biggest Moves & Fast Moving Stock Trade Plans - ulpravda.ru
1.04%
大文字化:
|
ボリューム (24 時間):